The current seasonal influenza vaccines (containing antigens derived from an H1N1, an H3N2 and one or two influenza B strains) and pandemic vaccine candidates are mainly based on the hemagglutinin (HA), which is, together with the neuraminidase (NA), the major glycoprotein of the virus envelope. This evidence concerns the gene XK and influenza.